Unicentric castleman disease complicated by paraneoplastic bronchiolitis obliterans and pemphigus
We describe 2 patients with unicentric Castleman disease complicated by paraneoplastic pemphigus and bronchiolitis obliterans. In addition to primary surgical resection for Castleman disease, we also used therapy from a treatment protocol used for bronchiolitis obliterans resulting from hematopoetic stem cell transplant (HSCT). We were able to treat the patients using intravenous immunoglobulin; rituximab; fluticasone, azithromycin, and monteleukast (FAM); and rosuvastatin therapy. One patient demonstrated a favorable response, while the other demonstrated minimal response to this therapy.
Source: Respiratory Medicine Case Reports - Category: Respiratory Medicine Source Type: research
More News: Autoimmune Disease | Azithromycin | Bronchiolitis | Cancer & Oncology | Carcinoid Tumor | Crestor | Flonase | Hematology | Melanoma | Paraneoplastic Syndrome | Pemphigus | Respiratory Medicine | Rituxan | Rosuvastatin | Skin Cancer | Stem Cell Therapy | Stem Cells | Transplants | Zithromax